Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

A revolutionary cell-based gene therapy is showing promise for treating autoimmune diseases. Professor Georg Schett, a ...

Enter MaxCyte, which has been developing and optimizing its Flow Electroporation® technology, allowing cells to move through ...

An innovative CRISPR-Cas12f-based activator system may hold significant ... in-depth framework for the advantages of including cell and gene therapy coverage in employer health plans, as well ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

A newly developed gene therapy shows great potential for treating glaucoma, a condition that can lead to vision loss.

Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to ...

Scientists at Trinity College Dublin have developed a promising gene therapy for glaucoma, shown to protect retinal cells and ...

Co-expressing NPY and its inhibitory receptor Y2 in excitatory hippocampal cells allows inhibitory autoregulation of ...

bluebird bio's Zynteglo has become the first cell-based gene therapy to be approved in the US, getting the nod from the FDA as a treatment for patients with beta thalassaemia who require regular ...

A new gene therapy has restored vision in patients with Leber congenital amaurosis type I (LCA1), a rare genetic condition ...

In the years since the first adeno-associated virus (AAV)-based gene therapy—voretigene ... Both the American Society of Gene and Cell Therapy and the European Society for Gene and Cell Therapy ...